Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
16.51
-0.14 (-0.84%)
Oct 14, 2026, 11:59 AM CST
SHE:003020 Revenue
Hefei Lifeon Pharmaceutical had revenue of 327.16M CNY in the quarter ending June 30, 2026, a decrease of -12.10%. This brings the company's revenue in the last twelve months to 1.51B, up 1.62% year-over-year. In the year 2025, Hefei Lifeon Pharmaceutical had annual revenue of 1.55B with 2.33% growth. That makes Hefei Lifeon Pharmaceutical the 16,559th largest company in the world by revenue and 2,982nd in China.
Revenue (ttm)
1.51B
Revenue Growth
+1.62%
P/S Ratio
2.52
Revenue / Employee
1.03M
Employees
1,465
Market Cap
3.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55B | 35.32M | 2.33% |
| Dec 31, 2024 | 1.52B | -382.30M | -20.11% |
| Dec 31, 2023 | 1.90B | -678.55M | -26.31% |
| Jan 1, 2023 | 2.58B | 306.09M | 13.46% |
| Dec 31, 2021 | 2.27B | 378.96M | 20.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.72B |
| Xiangxue Pharmaceutical | 1.48B |
| Pulike Biological Engineering | 1.02B |
| Beijing Bohui Innovation Biotechnology Group | 816.14M |
| Landfar Bio-medicine | 660.26M |
| Assure Tech (Hangzhou) | 410.36M |
| Beijing Scitop Bio-tech | 372.08M |
| Jiangsu Bioperfectus Technologies | 310.89M |